Argan's Power Trip: Great Business, Terrifying Chart, Insiders Cashing Out

Here's the setup that should make every AGX bull a little uncomfortable: the company is building the actual physical infrastructure America needs to keep the AI boom running, it just posted a $2.9 billion backlog, and its own executives have been selling stock like it's going out of style. Both things are true at once. Welcome to Argan.

The bull case is real, not hype. Argan is a small-cap EPC shop that happens to sit at the exact intersection of the two biggest infrastructure stories in the economy right now — the AI data center buildout and the scramble to add gas-fired generation capacity to feed it. Back on March 26, the company dropped record fiscal 2026 results that sent the stock up 19.6% in a single session, with Q4 revenue and earnings both blowing past estimates and a backlog print of $2.9 billion. Roughly 79% of that backlog, as of the end of April, is tied directly to rising power demand. Gross margins expanded to 25% in the print. This isn't a story stock riding vibes — Argan's Power segment did $756.5 million in revenue last fiscal year, about 80% of the whole company, and the tailwind behind it (utilities and hyperscalers desperate for anyone who can actually pour concrete and wire turbines) isn't going away next quarter. The balance sheet backs it up too: nearly $70 in cash per share and almost no debt. This is not a company that needs to raise capital or beg a bank for anything.

So what's the problem? The stock is up something like 92% year-to-date, and the market has priced in near-perfection. Forward multiples in the mid-30s to 40s-plus range are a lot to ask of a lumpy, project-based EPC business whose revenue can swing hard on the timing of a handful of large contracts. And then there's the tell that actually matters more than any Zacks headline: insiders have sold north of $40 million in stock over the past six months. When the people closest to the backlog and the margin trajectory are quietly stepping out the door in size, that's not nothing. It doesn't mean the business is broken — it might just mean a stock that's tripled wants some profit-taking from the people who bought it at a tenth the price. But it rhymes uncomfortably with "cyclical peak," and this business is cyclical almost by design.

The chart agrees with the skeptics more than the headlines do. AGX has gone from sharp rally to consolidation, stuck under resistance near $558 with support at $440 that actually matters — a break below there opens the door toward $396. The 50-day moving average is deeply negative on a percentage basis even after the run, RSI sits in no-man's-land around 44, and short interest is a non-trivial 6.7%. Translation: this is a stock digesting a huge move, not one confidently breaking out to new highs. Retail sentiment, by most accounts, remains bullish anyway — which is exactly the kind of divergence that precedes either a great buying opportunity or a painful flush.

The real catalyst is dead ahead. Argan reports Q2 fiscal 2027 earnings on September 3, with Wall Street looking for $2.68 in EPS. Given how binary these EPC prints tend to be for AGX — the stock's entire 2026 has been a series of gap moves around backlog updates and quarterly beats — this is the event that decides whether the current chop resolves up toward the high-$500s/$600s or down through $440 toward the $390s.

Here's my take: I don't think the AI-power-demand thesis is wrong, and I don't think Argan is a fraud or a fad. But a business this lumpy trading at this multiple, with insiders selling into strength and the tape already flashing exhaustion, is not a "buy and forget" story right now — it's a "wait for the print" story. Let September 3 tell you whether the backlog is converting into real, durable earnings growth or whether this was just the market front-running a supercycle that's already partly priced. Chase it above $580 with conviction if the number's clean. Otherwise, let the insiders finish their selling first — they clearly know something about timing that the retail crowd hasn't priced in yet.